Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer
Fiona Simpkins(The Wistar Institute), Ronny Drapkin(Cancer Research Center)
Cited by 2
Related Papers
Ovarian Cancer Pathogenesis: A Model in Evolution
|Journal of Oncology|2009|294
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i> -Mutant Ovarian Cancer Models
|Clinical Cancer Research|2016|292
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
|JCI Insight|2017|71